And I thought it was just your HCV, HBV and HIV divisions that were in serious trouble!!!
Comes from an Oncology Chatroom (café pharma)
"Well.....No way in hell I am going to this clown show with a bunch of neophyte managers that basically talked the whole time about how great this 2nd rate drug is.
Neat compound but second rate. Gilead bought it on the cheap cheap. Zero chatter among my docs for this "awesome new drug".
Very true…my docs are excited about ibrutinib and Gazyva….haven't heard a lot of excitement about idelalisib. Look like it will be a lot of Seattle Genetics reps and managers because of their subpar and unhappy culture. Better price it real cheap if you want usage. "
IGNORE MYPRIME AND GUGUY. Both are working on pumping/dumping (IDIX/GILD) for a HF who are heavily with short position on GILD. Both pretends #$%$ doctors but working on per listing basis as plus .95% listing on IDIX/GILD message board are from them..